García-Morales, C.; Tapia-Trejo, D.; Matías-Florentino, M.; Quiroz-Morales, V.S.; Dávila-Conn, V.; Beristain-Barreda, Á.; Cárdenas-Sandoval, M.; Becerril-Rodríguez, M.; Iracheta-Hernández, P.; Macías-González, I.;
et al. HIV Pretreatment Drug Resistance Trends in Mexico City, 2017–2020. Pathogens 2021, 10, 1587.
https://doi.org/10.3390/pathogens10121587
AMA Style
García-Morales C, Tapia-Trejo D, Matías-Florentino M, Quiroz-Morales VS, Dávila-Conn V, Beristain-Barreda Á, Cárdenas-Sandoval M, Becerril-Rodríguez M, Iracheta-Hernández P, Macías-González I,
et al. HIV Pretreatment Drug Resistance Trends in Mexico City, 2017–2020. Pathogens. 2021; 10(12):1587.
https://doi.org/10.3390/pathogens10121587
Chicago/Turabian Style
García-Morales, Claudia, Daniela Tapia-Trejo, Margarita Matías-Florentino, Verónica Sonia Quiroz-Morales, Vanessa Dávila-Conn, Ángeles Beristain-Barreda, Miroslava Cárdenas-Sandoval, Manuel Becerril-Rodríguez, Patricia Iracheta-Hernández, Israel Macías-González,
and et al. 2021. "HIV Pretreatment Drug Resistance Trends in Mexico City, 2017–2020" Pathogens 10, no. 12: 1587.
https://doi.org/10.3390/pathogens10121587
APA Style
García-Morales, C., Tapia-Trejo, D., Matías-Florentino, M., Quiroz-Morales, V. S., Dávila-Conn, V., Beristain-Barreda, Á., Cárdenas-Sandoval, M., Becerril-Rodríguez, M., Iracheta-Hernández, P., Macías-González, I., García-Mendiola, R., Guzmán-Carmona, A., Zarza-Sánchez, E., Cruz, R. A., González-Rodríguez, A., Reyes-Terán, G., & Ávila-Ríos, S.
(2021). HIV Pretreatment Drug Resistance Trends in Mexico City, 2017–2020. Pathogens, 10(12), 1587.
https://doi.org/10.3390/pathogens10121587